In Alzheimers patients develop beta-amyloid plaques as a response to the chronic inflammatory process
Key Takeaways Market Scale : The GLP-1 market is projected to exceed $200 billion by 2033, making it the most significant therapeutic class for capital allocation in the next decade
Research indicates the peptide crosses the blood-brain barrier, potentially offering neuroprotective benefits (Sikiric et al., Current Pharmaceutical Design, 2020)
carbonated beverages including soda and excessive sparkling water (increase bloating and reflux)
CJC-1295 mimics the action of growth hormone-releasing hormone, prompting the pituitary gland to increase growth hormone production over time
Food and Drug Administration for diabetic peripheral neuropathy: duloxetine (Cymbalta), pregabalin (Lyrica), tapentadol (available as brand Nucynta extended-release), and capsaicin patch (Qutenza)